# Risankizumab

## Skyrizi 75mg-0.83mL pre-filled syringe

*藥物代碼*：ISKY

*給藥途徑*：I

*用法用量*：

The recommended dose is 150 mg (two 75 mg injections) administered by subcutaneous injection at Week 0, Week 4, and every 12 weeks thereafter.

## 試ABBV-066-M15-997 (Risankizumab 75mg)

*藥物代碼*：RIAB066

*給藥途徑*：I

*用法用量*：

na

